Posting of Annual Report and Notice of AGM

RNS Number : 0160M
Directa Plus PLC
19 May 2022
 

19 May 2022

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Posting of Annual Report and Notice of Annual General Meeting

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene-based products for use in consumer and industrial markets, announces that the Company's Annual Report and Accounts for the year ended 31 December 2021, together with the notice (the "Notice") of the Company's annual general meeting ("AGM") have been posted to shareholders and will be available shortly on the Company's website.

 

The AGM will be held on Friday, 17 June 2022 at 10.30 a.m. at 11-12 St. James's Square, London, SW1Y 4LB.

 

The Notice sets out the resolutions to be considered and, if appropriate, passed at the AGM. In line with the requirements of the Company's Articles of Association, the resolutions include proposals for the re-election of at least one-third of the Board of Directors, notwithstanding that those individuals may already have been re-elected within a three-year period. At the forthcoming AGM, the Directors nominated for re-election will be Sir Peter Middleton (Chairman) and Giulio Cesareo (CEO).

 

However, Shareholders should note that Sir Peter has indicated his intention to step down as Chairman of Directa Plus and from the Board of Directors prior to the next AGM, and as soon as a process to identify and appoint a suitable successor has been completed. The Board of Directors is also committed to a broader process to review and refresh the constitution of the Board, in particular to bring additional diversity and expertise to the Company. This process will be overseen by Neil Warner, the Senior Independent Non-Executive Director of the Company, and further updates will follow in due course.

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO / Giorgio Bonfanti, CFO




Cenkos Securities plc (Nominated Adviser and Joint Broker)

+44 131 220 6939

Neil McDonald / Adam Rae




Singer Capital Markets (Joint Broker)

+44 20 7496 3069

Rick Thompson / Phil Davies




Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson / Heather Armstrong


 

About Directa Plus

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.

 

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products. Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+®) have multiple applications due to its properties. These G+® products can be categorised into various families, with different products being suitable for specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. The Company holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAGPUWAAUPPGQR
UK 100

Latest directors dealings